Phencyclidine supersensitivity in rats with neonatal dopamine loss

Psychopharmacology

Volumn 161, Issue 3, 2002, Pages 255-262

  Moy, Sheryl S ^a   Breese, George R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Haloperidol; Locomotor activity; Neonatal dopamine lesion; NMDA antagonist; Olanzapine; Sensitization

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PHENCYCLIDINE; AMINO ACID RECEPTOR BLOCKING AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; OXIDOPAMINE; PIRENZEPINE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG RESPONSE; DRUG SELECTIVITY; DRUG SENSITIVITY; DRUG SENSITIZATION; ELECTROENCEPHALOGRAM; FEMALE; LOCOMOTION; MALE; MUSCULOSKELETAL SYSTEM; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RAT STRAIN; SENSITIZATION; SUPERSENSITIVITY; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SEX DIFFERENCE; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMAL; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; COMPARATIVE STUDY; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HALOPERIDOL; KETAMINE; MALE; MOTOR ACTIVITY; OXIDOPAMINE; PHENCYCLIDINE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; SCH-23390; SEX FACTORS; SK AND F-38393; SUPPORT, NON-U.S. GOV'T; (R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BENZODIAZEPINES;

EID: 0035991064     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1017-2     Document Type: Article

References (43)

1. Serotonin model of schizophrenia: Emerging role of glutamate mechanisms
2. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine
3. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: Effects of 6-hydroxydopamine
4. Behavioral differences between neonatal and young adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine
5. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine
6. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopimine at differing ages: Functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats
7. Radioreceptor binding profile of the atypical antipsychotic olanzapine
8. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
9. Neurotransmitter interactions in schizophrenia - Therapeutic implications
10. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
11. Animal models of negative symptoms: M100907 antagonizes PCP-induced immobility in a forced swim test in mice
12. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats
13. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats
14. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice
15. Dopaminergic sensitization: Implications for the pathogenesis of schizophrenia
16. Sex differences in NMDA receptor mediated responses in rats
17. Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats
18. Recent advances in the phencyclidine model of schizophrenia
19. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
20. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
21. 1 receptors mediate enhanced oral activity after neonatal 6-OHDA
22. 2 dopamine receptors
23. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs
24. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
25. Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity
26. The behavioural effects of MK-801 in rats: Involvement of dopaminergic, serotonergic and noradrenergic systems
27. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine
28. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
29. MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
30. 2A receptors
31. Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia
32. 1-dopamine receptors in rats with neonatal dopamine loss
33. Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats
34. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: Imbalance of prefrontal serotonergic and dopaminergic functions
35. Excitatory amino acids and neuropsychiatric disorders
36. Glutamate receptor dysfunction and schizophrenia
37. Repeated intraventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge
38. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
39. 1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat
40. Seroquel restores sensorimotor gating in phencyclidine-treated rats
41. Schizophrenia and glutamatergic transmission
42. 1 receptors in phencyclidine-induced behavioral stimulation in rats
43. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice